John R Petrie

Hypertension in diabetes: when two worlds collide
The British Journal of Diabetes & Vascular Disease 2003 3: 243-244. [PDF] [References]  

Morris J Brown

Review: Implications from hypertension outcome trials for the management of patients with hypertension and diabetes
The British Journal of Diabetes & Vascular Disease 2003 3: 245-251. [Abstract] [PDF] [References]  

Sarah Ross and Mary-Joan Macleod

Review: Hypertension in diabetes: a perspective from clinical pharmacology
The British Journal of Diabetes & Vascular Disease 2003 3: 252-256. [Abstract] [PDF] [References]  

John R Petrie

Blood pressure measurement in diabetes: theory and practice
The British Journal of Diabetes & Vascular Disease 2003 3: 258-261. [Abstract] [PDF] [References]  

Gordon T Mcinnes

`Size is not everything`: the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT): The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomised to angiotensin-converting enzyme inhibitor or calcium channel blocker versus diuretic. The Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT)
The British Journal of Diabetes & Vascular Disease 2003 3: 263-267. [Abstract] [PDF] [References]  

John R Petrie and Mike Kirby

Commonly asked questions: hypertension
The British Journal of Diabetes & Vascular Disease 2003 3: 270-273. [PDF] [References]  

Caroline Daly and Henry Purcell

Optimising treatment of hypertension to prevent cardiovascular complications in type 2 diabetes
The British Journal of Diabetes & Vascular Disease 2003 3: 274-276. [Abstract] [PDF] [References]  

Thomas Kaiser, Christiane Florack, Uta Stephan, and Peter T Sawicki

Should BP targets be lower in diabetic patients with microalbuminuria or nephropathy? A systematic review of randomised controlled trials
The British Journal of Diabetes & Vascular Disease 2003 3: 278-281. [Abstract] [PDF] [References]  

James D Walker

Commentary: Should BP targets be lower in diabetic patients with microalbuminuria or nephropathy?
The British Journal of Diabetes & Vascular Disease 2003 3: 282-284. [Abstract] [PDF] [References]  

Peter T Sawicki and Thomas Kaiser

Reply: Should BP targets be lower in diabetic patients with microalbuminuria or nephropathy?
The British Journal of Diabetes & Vascular Disease 2003 3: 285. [PDF] [References]  

Francesco P Cappuccio, Antonio Barbato, and Sally M Kerry

Hypertension, diabetes and cardiovascular risk in ethnic minorities in the UK
The British Journal of Diabetes & Vascular Disease 2003 3: 286-293. [Abstract] [PDF] [References]  

Naveed Sattar

Commentary: Documenting ethnic variations in vascular risk: where do we go from here?
The British Journal of Diabetes & Vascular Disease 2003 3: 294. [PDF] [References]  

Susan Kennedy

Comparing audits of cardiovascular risk in patients with diabetes in primary care
The British Journal of Diabetes & Vascular Disease 2003 3: 295-299. [Abstract] [PDF] [References]  

Yee Ping Teoh and John R Petrie

Candy in the clinic: resistant hypertension in diabetes
The British Journal of Diabetes & Vascular Disease 2003 3: 300-301. [PDF] [References]  

Jean-Claude Mamputu, Nicolas Wiernsperger, and Geneviève Renier

Metformin inhibits monocyte adhesion to endothelial cells and foam cell formation
The British Journal of Diabetes & Vascular Disease 2003 3: 302-310. [Abstract] [PDF] [References]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.